下一代测序定义了一个分子确认的ARPKD核心在更广泛的PKHD1相关疾病谱中
Paloma Lapunzina-Soler1, Amir Shabaka2, Ramón Peces2
1Escuela de Doctorado, Universidad de Navarra, 31009 Pamplona, Spain.
Genes
|February 27, 2026
概括
自体递归多囊性病 (ARPKD) 的诊断是通过分析PKHD1变异来改进的. 功能丧失的等位基因负担决定了脏的严重程度,而肝脏疾病是独立于切断等位基因的.
科学领域:
- 遗传学 是一个遗传学.
- 儿科脏病学 儿科脏病学
- 医学基因组学 医学基因组学
背景情况:
- 自体递归多囊性病 (ARPKD) 是一种严重的病,与PKHD1基因变异有关.
- 下一代测序 (NGS) 已经确定了许多罕见的PKHD1变异,使ARPKD诊断复杂化.
- 将分子确认的ARPKD与更广泛的PKHD1-相关疾病区分开来是具有挑战性的.
研究的目的:
- 整合临床和分子数据以准确诊断ARPKD.
- 根据PKHD1变体的致病性和发病性对患者进行分层.
- 在分子确认的ARPKD中建立基因型-表型相关性.
主要方法:
- 对68名疑似ARPKD患者进行了综合临床和分子分析.
- 使用阶段感知和家庭信息的ACMG分类来解释变异.
- 将患者分为证实ARPKD,不确定的致病性和载体组.
主要成果:
- 40名患者有分子确认的ARPKD,具有不同的功能丧失 (LoF) 基因负担.
- 在病发病和进展到替代疗法时观察到显著的等位基因剂量效应.
- 在所有基因型组中,肝病的患病率很高,与LoF负担没有显著的关联.
结论:
- 对PKHD1变异的阶段感知解释准确地定义了ARPKD核心.
- 在ARPKD中,LoF等位基因负担是和围产期严重性的关键决定因素.
- 在ARPKD中肝脏的参与在很大程度上独立于切断等位基因负担,有助于预后和遗传咨询.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
34.9K
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
39.4K
相关概念视频
Next-generation Sequencing
99.5K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
99.5K
Genome-wide Association Studies-GWAS
16.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.0K
Karyotyping
69.1K
Overview
69.1K
Animal Mitochondrial Genetics
9.6K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.6K
Single Nucleotide Polymorphisms-SNPs
18.8K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.8K
